Key facts
- This page summarizes Ramesh Kumar's Form 4 filing for Ocugen, Inc. (OCGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Jul 2022, 16:19.
Ramesh Kumar - 18 Jul 2022 Form 4 Insider Report for Ocugen, Inc. (OCGN)
- Reporting relationship
- Director
- Issuer ticker
- OCGN
- Reported as of
- 18 Jul 2022
- Net transaction value
- -$15,450
- SEC form
- 4
- Accepted by SEC
- 20 Jul 2022, 16:19:18 UTC
- Prior SEC filing
- 08 Jun 2022
- Next SEC filing
- 07 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ramesh Kumar by Shankar Musunuri, his attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ramesh Kumar filed Form 4 for Ocugen, Inc. (OCGN) on 20 Jul 2022.
Change
- Previous filing in this sequence was filed on 08 Jun 2022.
- Current net transaction value: -$15,450.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCGN
transaction
Common Stock
Options Exercise
- Transaction value
- $3,825
- Shares
- +7,500
- Change %
- Price
- $0.5100
- Shares after
- 7,500
- Date
- 18 Jul 2022
- Ownership
- Direct
OCGN
transaction
Common Stock
Sale
- Transaction value
- $19,275
- Shares
- -7,500
- Change %
- -100%
- Price
- $2.57*
- Shares after
- 0
- Date
- 18 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCGN
transaction
Derivative
Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- +7,500
- Change %
- +500%
- Price
- $0.000000
- Shares after
- 9,000
- Date
- 18 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $0.5100
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Footnote F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.56 to $2.61. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Footnote F3
The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.